Literature DB >> 24890978

The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma.

Federico Maria Gioacchini1, Matteo Alicandri-Ciufelli, Giuseppe Magliulo, Corrado Rubini, Livio Presutti, Massimo Re.   

Abstract

The aim of this study was to determine the prognostic value of Ki-67 immunostaining in patients affected by laryngeal squamous cell carcinoma. A systematic review was carried out in a tertiary university referral center. An appropriate string was run on PubMed to retrieve articles dealing with Ki-67 immunohistochemical staining and laryngeal squamous cell carcinoma. A double cross-check was performed on citations and full-text articles by two investigators independently to review all manuscripts and perform a comprehensive quality assessment. Of 85 abstracts identified, 18 articles were included. These studies reported on 1,342 patients with histological confirmed diagnosis of laryngeal squamous cell carcinoma. Most studies showed a statistical association between Ki-67 immunohistochemical expression and at least one of the clinical and histopathological parameters considered by the authors. Overall the studies analyzed suggested that the tumoral proliferative index was statistically connected respectively with T stage (2/18), N stage (4/18), grading (6/18), disease-free survival (10/18) and overall survival (4/18). Our review strongly suggests that immunohistochemical staining of Ki-67 correlates with tumoral aggressiveness and worse prognosis in patients affected by laryngeal squamous cell carcinoma. Further high-quality prospective studies should be carried out to confirm our finding and determine the eventual differences between cancers of specific laryngeal subsites.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24890978     DOI: 10.1007/s00405-014-3117-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  43 in total

1.  c-myc and bcl-2 Expression in supraglottic squamous cell carcinoma of the larynx.

Authors:  Ali Ozdek; Sarp Sarac; M Umut Akyol; Arzu Sungur; Taner Yilmaz
Journal:  Otolaryngol Head Neck Surg       Date:  2004-07       Impact factor: 3.497

2.  P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.

Authors:  P Lavertu; D J Adelstein; J Myles; M Secic
Journal:  Laryngoscope       Date:  2001-11       Impact factor: 3.325

3.  Ki-67 and p53 in T2 laryngeal cancer.

Authors:  A Kropveld; P J Slootweg; M A Blankenstein; C H Terhaard; G J Hordijk
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

Review 4.  Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation.

Authors:  Phillipe Lothaire; Evandro de Azambuja; Didier Dequanter; Yassine Lalami; Christos Sotiriou; Guy Andry; Gilberto Castro; Ahmad Awada
Journal:  Head Neck       Date:  2006-03       Impact factor: 3.147

5.  Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions.

Authors:  T Krecicki; M Jeleń; M Zalesska-Krecicka; J Rak; T Szkudlarek; J Jeleń-Krzeszewska
Journal:  Oral Oncol       Date:  1999-03       Impact factor: 5.337

6.  [Expression of proliferation markers PCNA and MIB 1 in verrucous squamous epithelial carcinoma of the oral cavity].

Authors:  D Theegarten; A Barfuss; N C Gellrich; S Philippou
Journal:  Mund Kiefer Gesichtschir       Date:  1997-05

7.  Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia.

Authors:  H Izawa; N Yonemitsu; T Shin; H Sugihara
Journal:  Auris Nasus Larynx       Date:  1999-07       Impact factor: 1.863

8.  p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.

Authors:  D Mielcarek-Kuchta; J Olofsson; W Golusinski
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

Review 9.  Prognostic relevance of cell proliferation in head and neck tumors.

Authors:  A Pich; L Chiusa; R Navone
Journal:  Ann Oncol       Date:  2004-09       Impact factor: 32.976

10.  Cyclin D1, p53, MIB1, intratumoral microvessel density, and human papillomavirus in advanced laryngeal carcinoma: association with nodal metastasis.

Authors:  Rekha V Kumar; Ashok M Shenoy; Richard Daniel; Keerti V Shah
Journal:  Otolaryngol Head Neck Surg       Date:  2004-10       Impact factor: 3.497

View more
  16 in total

1.  Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma.

Authors:  Toshiya Maebayashi; Naoya Ishibashi; Takuya Aizawa; Masakuni Sakaguchi; Tsutomu Saito; Jiro Kawamori; Yoshiaki Tanaka; Yukari Hirotani; Taku Homma
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-12       Impact factor: 2.503

Review 2.  The prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma.

Authors:  Federico M Gioacchini; Matteo Alicandri-Ciufelli; Shaniko Kaleci; Giuseppe Magliulo; Livio Presutti; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-12       Impact factor: 2.503

Review 3.  Malignant transformation of sinonasal inverted papilloma and related genetic alterations: a systematic review.

Authors:  M Re; F M Gioacchini; A Bajraktari; M Tomasetti; S Kaleci; C Rubini; A Bertini; G Magliulo; E Pasquini
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-21       Impact factor: 2.503

4.  Using RNA sequencing to identify a putative lncRNA-associated ceRNA network in laryngeal squamous cell carcinoma.

Authors:  Kexing Lyu; Yun Li; Yang Xu; Huijun Yue; Yihui Wen; Tesi Liu; Siyu Chen; Qihong Liu; Weiqiang Yang; Xiaolin Zhu; Zhangfeng Wang; Liping Chai; Weiping Wen; Chunwei Li; Wenbin Lei
Journal:  RNA Biol       Date:  2020-03-30       Impact factor: 4.652

5.  Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma.

Authors:  Alexey Surov; Hans Jonas Meyer; Anne-Kathrin Höhn; Karsten Winter; Osama Sabri; Sandra Purz
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

6.  Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.

Authors:  Massimo Re; Giuseppe Magliulo; Federico M Gioacchini; Arisa Bajraktari; Andrea Bertini; Artan Çeka; Corrado Rubini; Luigi Ferrante; Antonio D Procopio; Fabiola Olivieri
Journal:  Biomed Res Int       Date:  2017-08-31       Impact factor: 3.411

7.  The prognostic significance of E-cadherin expression in laryngeal squamous-cell carcinoma: a systematic review.

Authors:  M Re; F M Gioacchini; A Scarpa; C Cassandro; M Tulli; E Cassandro
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-11-09       Impact factor: 2.124

8.  Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity.

Authors:  Zhan Yang; Wei Du; Xu Zhang; Defeng Chen; Qigen Fang; Yuezhong He; Yang Yang; Ding Li; Jie Fan
Journal:  Front Oncol       Date:  2021-06-28       Impact factor: 6.244

9.  Combined Metabolo-Volumetric Parameters of 18F-FDG-PET and MRI Can Predict Tumor Cellularity, Ki67 Level and Expression of HIF 1alpha in Head and Neck Squamous Cell Carcinoma: A Pilot Study.

Authors:  Alexey Surov; Hans Jonas Meyer; Anne Kathrin Höhn; Osama Sabri; Sandra Purz
Journal:  Transl Oncol       Date:  2018-09-18       Impact factor: 4.243

10.  Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients.

Authors:  Dan-Ming Wei; Wen-Jie Chen; Rong-Mei Meng; Na Zhao; Xiang-Yu Zhang; Dan-Yu Liao; Gang Chen
Journal:  Respir Res       Date:  2018-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.